Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2012 5
2013 10
2014 15
2015 18
2016 7
2017 1
2018 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for jia hui zhen
Search for Jia-Huei Chen instead (2 results)
MicroRNA-223 is involved in the pathogenesis of atopic dermatitis by affecting histamine-N-methyltransferase.
Jia HZ, Liu SL, Zou YF, Chen XF, Yu L, Wan J, Zhang HY, Chen Q, Xiong Y, Yu B, Zhang W. Jia HZ, et al. Cell Mol Biol (Noisy-le-grand). 2018 Feb 28;64(3):103-107. doi: 10.14715/cmb/2018.64.3.17. Cell Mol Biol (Noisy-le-grand). 2018. PMID: 29506638
[Hypoxia-responsive factor PHD2 and angiogenic diseases].
Jia HZ, Kasim V, Xu ZL, Yang L, Wu SR. Jia HZ, et al. Yao Xue Xue Bao. 2014 Feb;49(2):151-7. Yao Xue Xue Bao. 2014. PMID: 24761603 Review. Chinese.
Multifunctional Nanotherapeutics with All-in-One Nanoentrapment of Drug/Gene/Inorganic Nanoparticle.
Jia HZ, Wang W, Zheng DW, Wang X, Yu WY, Li SY, Zhuo RX, Zhao YF, Feng J, Zhang XZ. Jia HZ, et al. ACS Appl Mater Interfaces. 2016 Mar 23;8(11):6784-9. doi: 10.1021/acsami.6b01046. Epub 2016 Mar 14. ACS Appl Mater Interfaces. 2016. PMID: 26962876
Mitochondria-Targeted Chimeric Peptide for Trinitarian Overcoming of Drug Resistance.
Han K, Zhu JY, Jia HZ, Wang SB, Li SY, Zhang XZ, Han HY. Han K, et al. Among authors: jia hz. ACS Appl Mater Interfaces. 2016 Sep 28;8(38):25060-8. doi: 10.1021/acsami.6b06522. Epub 2016 Sep 13. ACS Appl Mater Interfaces. 2016. PMID: 27595983
LncRNA H19 regulates ID2 expression through competitive binding to hsa-miR-19a/b in acute myelocytic leukemia.
Zhao TF, Jia HZ, Zhang ZZ, Zhao XS, Zou YF, Zhang W, Wan J, Chen XF. Zhao TF, et al. Among authors: jia hz. Mol Med Rep. 2017 Sep;16(3):3687-3693. doi: 10.3892/mmr.2017.7029. Epub 2017 Jul 18. Mol Med Rep. 2017. PMID: 28765931
Bioinspired Nano-Prodrug with Enhanced Tumor Targeting and Increased Therapeutic Efficiency.
Chen WH, Lei Q, Yang CX, Jia HZ, Luo GF, Wang XY, Liu G, Cheng SX, Zhang XZ. Chen WH, et al. Among authors: jia hz. Small. 2015 Oct 21;11(39):5230-42. doi: 10.1002/smll.201500920. Epub 2015 Aug 19. Small. 2015. PMID: 26285687
Multifunctional theranostic nanoplatform for cancer combined therapy based on gold nanorods.
Chen WH, Yang CX, Qiu WX, Luo GF, Jia HZ, Lei Q, Wang XY, Liu G, Zhuo RX, Zhang XZ. Chen WH, et al. Among authors: jia hz. Adv Healthc Mater. 2015 Oct 28;4(15):2247-59. doi: 10.1002/adhm.201500453. Epub 2015 Sep 1. Adv Healthc Mater. 2015. PMID: 26333115
An innovative pre-targeting strategy for tumor cell specific imaging and therapy.
Qin SY, Peng MY, Rong L, Jia HZ, Chen S, Cheng SX, Feng J, Zhang XZ. Qin SY, et al. Among authors: jia hz. Nanoscale. 2015 Sep 21;7(35):14786-93. doi: 10.1039/c5nr03862f. Nanoscale. 2015. PMID: 26287473
Acidity-responsive gene delivery for "superfast" nuclear translocation and transfection with high efficiency.
Zhu JY, Zeng X, Qin SY, Wan SS, Jia HZ, Zhuo RX, Feng J, Zhang XZ. Zhu JY, et al. Among authors: jia hz. Biomaterials. 2016 Mar;83:79-92. doi: 10.1016/j.biomaterials.2016.01.003. Epub 2016 Jan 4. Biomaterials. 2016. PMID: 26773666
Fabrication of dual responsive co-delivery system based on three-armed peptides for tumor therapy.
Chen S, Lei Q, Li SY, Qin SY, Jia HZ, Cheng YJ, Zhang XZ. Chen S, et al. Among authors: jia hz. Biomaterials. 2016 Jun;92:25-35. doi: 10.1016/j.biomaterials.2016.03.031. Epub 2016 Mar 21. Biomaterials. 2016. PMID: 27031930
46 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback